Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes - Rathmann, W; Strassburger, K; Bongaerts, B (Diabetes Obes Metab, 2017)
et al.